Seong-Ho Kang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Seong-Ho Kang has a total of 66 co-authors. Here are the top co-authors by number of shared publications:
- Geon Park
Department of Laboratory Medicine, Chosun University Hospital, Gwangju, Korea
10 shared publications Dae-Soo Moon
Department of Laboratory Medicine, Chosun University College of Medicine, Gwangju, Korea
4 shared publicationsIn-Sun Choi
Department of Laboratory Medicine, Chosun University College of Medicine, Gwangju, Korea
3 shared publicationsJi Seon Choi
International St. Mary’s Hospital, Catholic Kwandong University, Incheon, Korea
3 shared publicationsJi-Seon Choi
Department of Laboratory Medicine, International St. Mary's Hospital, Catholic Kwandong University, Incheon, Republic of Korea
3 shared publications- Joong-Ki Kook
Korean Collection for Oral Microbiology and Oral Bacterial Pathogen Resource Specialized Bank, Chosun University, Gwangju 61452, Republic of Korea
3 shared publications
Latest Publications
- Open Access
- 1 July 2025
- Published by Laboratory Medicine Online in Laboratory Medicine Online
- Vol. 15 (3) , 256-260
Chronic Neutrophilic Leukemia with Initial Leukopenia: A Case Report and Review of the Literature
Sangha Lee, M.D., Seul-Bi Lee, M.D., Hyun-Young Kim, M.D., Sang-Mi Kim, M.D., Heerah Lee, M.D., Young Jin Ko, M.D., Geon Park, M.D., Seong-Ho Kang, M.D.. Lab Med Online 2025;15:256-60. https://doi.org/10.47429/lmo.2025.15.3.256
- 1 July 2025
- Published by Laboratory Medicine Online in Laboratory Medicine Online
- Vol. 15 (3) , 256-260
Open AccessChronic Neutrophilic Leukemia with Initial Leukopenia: A Case Report and Review of the Literature
Sangha Lee, M.D., Seul-Bi Lee, M.D., Hyun-Young Kim, M.D., Sang-Mi Kim, M.D., Heerah Lee, M.D., Young Jin Ko, M.D., Geon Park, M.D., Seong-Ho Kang, M.D.. Lab Med Online 2025;15:256-60. https://doi.org/10.47429/lmo.2025.15.3.256
- Open Access
- 27 May 2024
- Published by Springer Nature in Blood Research
- Vol. 59 (1) , 1-3
Correction: MicroRNA-765 is upregulated in myelodysplastic syndromes and induces apoptosis via PLP2 inhibition in leukemia cells
- 27 May 2024
- Published by Springer Nature in Blood Research
- Vol. 59 (1) , 1-3
Open AccessCorrection: MicroRNA-765 is upregulated in myelodysplastic syndromes and induces apoptosis via PLP2 inhibition in leukemia cells
- Open Access
- 27 July 2023
- Published by Springer Nature in Blood Research
- Vol. 58 (3) , 133-137
MicroRNA-765 is upregulated in myelodysplastic syndromes and induces apoptosis via PLP2 inhibition in leukemia cells
Seong-Ho Kang, Ji Seon Choi. Blood Res 2023;58:133-7. https://doi.org/10.5045/br.2023.2023097
- 27 July 2023
- Published by Springer Nature in Blood Research
- Vol. 58 (3) , 133-137
Open AccessMicroRNA-765 is upregulated in myelodysplastic syndromes and induces apoptosis via PLP2 inhibition in leukemia cells
Seong-Ho Kang, Ji Seon Choi. Blood Res 2023;58:133-7. https://doi.org/10.5045/br.2023.2023097
- 7 September 2022
- Published by Wiley in European Journal of Haematology
- Vol. 109 (6) , 680-685
Upregulation of microRNA‐597 in myelodysplastic syndromes induces apoptosis through FOSL2 inhibition
Introduction Dysregulation of microRNAs (miRNAs) has been associated with the pathophysiology of myelodysplastic syndrome (MDS). Trisomy 8 is the most frequent chromosomal abnormalities in Korean patients with MDS. We investigated the dysregulation of miR-597-5p, located on chromosome 8, which is reported to induce cell death in numerous cancers. Materials and Methods We compared the expression profiles of miR-597-5p among 65 MDS patients and 11 controls, and analyzed the in vitro effects of miR-597 on leukemic cells using an acute myeloid leukemia cell line transfected with miR-597. Results We found that miR-597-5p levels were upregulated 4.05-fold in MDS patients compared to those in controls. In vitro study results demonstrated that transfection with a miR-597 mimic induced apoptosis through downregulation of FOS like 2 (FOSL2). Conclusion These findings suggest that upregulation of miR-597 induces apoptosis and that miR-597 has a possible role in the pathophysiology of MDS.
- 7 September 2022
- Published by Wiley in European Journal of Haematology
- Vol. 109 (6) , 680-685
Upregulation of microRNA‐597 in myelodysplastic syndromes induces apoptosis through FOSL2 inhibition
Introduction Dysregulation of microRNAs (miRNAs) has been associated with the pathophysiology of myelodysplastic syndrome (MDS). Trisomy 8 is the most frequent chromosomal abnormalities in Korean patients with MDS. We investigated the dysregulation of miR-597-5p, located on chromosome 8, which is reported to induce cell death in numerous cancers. Materials and Methods We compared the expression profiles of miR-597-5p among 65 MDS patients and 11 controls, and analyzed the in vitro effects of miR-597 on leukemic cells using an acute myeloid leukemia cell line transfected with miR-597. Results We found that miR-597-5p levels were upregulated 4.05-fold in MDS patients compared to those in controls. In vitro study results demonstrated that transfection with a miR-597 mimic induced apoptosis through downregulation of FOS like 2 (FOSL2). Conclusion These findings suggest that upregulation of miR-597 induces apoptosis and that miR-597 has a possible role in the pathophysiology of MDS.
- 13 September 2021
- Published by Wiley in Microbiology and Immunology
- Vol. 65 (12) , 566-574
Performance assessment of ASTA MicroIDSys, a new matrix assisted laser desorption ionization‐time of flight mass spectrometry system, for identification of viridans group streptococci
The performance of the ASTA MicroIDSys system (ASTA), a new matrix‐assisted laser desorption ionization time‐of‐flight mass spectrometry (MALDI‐TOF MS) system, was evaluated for the identification of viridans group streptococci (VGS) and compared with the results obtained with the Bruker Biotyper system (Bruker Daltonics). A total of 106 Streptococcus reference strains belonging to 24 species from the bacterial strain bank was analyzed using the two MALDI‐TOF MS systems. Of the 106 reference strains tested, ASTA MicroIDSys and Bruker Biotyper correctly identified 84.9% and 81.1% at the species level, 100% and 97.2% at the group level and 100% and 98.1% at the genus level, respectively. The difference between the two systems was not statistically significant (P = 0.289). Out of 24 species, 13 species were accurately identified to the species level with 100% accurate identification rates with both systems. The accurate identification rates at the species level of ASTA MicroIDSys and Bruker Biotyper were 100% and 87.5% for the S. anginosus group; 78.4% and 73.5% for the S. mitis group; 91.7% and 91.7% for the S. mutans group; and 100% and 100% for the S. salivarius group, respectively. The ASTA MicroIDSys showed an identification performance equivalent to that of the Bruker Biotyper for VGS. Therefore, it would be useful for the identification of VGS strains in clinical microbiology laboratories.
- 13 September 2021
- Published by Wiley in Microbiology and Immunology
- Vol. 65 (12) , 566-574
Performance assessment of ASTA MicroIDSys, a new matrix assisted laser desorption ionization‐time of flight mass spectrometry system, for identification of viridans group streptococci
The performance of the ASTA MicroIDSys system (ASTA), a new matrix‐assisted laser desorption ionization time‐of‐flight mass spectrometry (MALDI‐TOF MS) system, was evaluated for the identification of viridans group streptococci (VGS) and compared with the results obtained with the Bruker Biotyper system (Bruker Daltonics). A total of 106 Streptococcus reference strains belonging to 24 species from the bacterial strain bank was analyzed using the two MALDI‐TOF MS systems. Of the 106 reference strains tested, ASTA MicroIDSys and Bruker Biotyper correctly identified 84.9% and 81.1% at the species level, 100% and 97.2% at the group level and 100% and 98.1% at the genus level, respectively. The difference between the two systems was not statistically significant (P = 0.289). Out of 24 species, 13 species were accurately identified to the species level with 100% accurate identification rates with both systems. The accurate identification rates at the species level of ASTA MicroIDSys and Bruker Biotyper were 100% and 87.5% for the S. anginosus group; 78.4% and 73.5% for the S. mitis group; 91.7% and 91.7% for the S. mutans group; and 100% and 100% for the S. salivarius group, respectively. The ASTA MicroIDSys showed an identification performance equivalent to that of the Bruker Biotyper for VGS. Therefore, it would be useful for the identification of VGS strains in clinical microbiology laboratories.
- Open Access
- 1 April 2021
- Published by Laboratory Medicine Online in Laboratory Medicine Online
- Vol. 11 (2) , 135-138
Neurofibromatosis Type I: Case Reports of Two Novel Mutations
Ho Jong Lee, M.D., Ung Jun Kim, M.D., Woo Shin Kim, M.D., Young Jin Ko, M.D., Geon Park, M.D., Sook Jin Jang, M.D., Seong-Ho Kang, M.D.. Lab Med Online 2021;11:135-8. https://doi.org/10.47429/lmo.2021.11.2.135
- 1 April 2021
- Published by Laboratory Medicine Online in Laboratory Medicine Online
- Vol. 11 (2) , 135-138
Open AccessNeurofibromatosis Type I: Case Reports of Two Novel Mutations
Ho Jong Lee, M.D., Ung Jun Kim, M.D., Woo Shin Kim, M.D., Young Jin Ko, M.D., Geon Park, M.D., Sook Jin Jang, M.D., Seong-Ho Kang, M.D.. Lab Med Online 2021;11:135-8. https://doi.org/10.47429/lmo.2021.11.2.135
- 6 May 2019
- Published by Taylor & Francis in Leukemia & Lymphoma
- Vol. 60 (11) , 2779-2786
MicroRNA-661 upregulation in myelodysplastic syndromes induces apoptosis through p53 activation and associates with decreased overall survival
MicroRNA (miRNA) dysregulation contributes to myelodysplastic syndromes (MDS), and apoptosis is one of the pathogenic features of MDS. We investigated the dysregulation of miRNA expression and its biological significance in MDS. We compared the expression profiles of miRNAs encoded by chromosome 8 in 65 patients with MDS and 11 controls, and analyzed the in vitro effect of the upregulated miRNA expression. We found that compared to the controls, miR-661 was upregulated by 5.28-fold in patients with MDS. Patients with high miR-661 expression showed significantly decreased overall survival. In vitro study results demonstrated that transfection with a miR-661 mimic induced apoptosis through the activation of p53. These findings suggest that high miR-661 expression can be associated with decreased overall survival and recapitulates apoptosis, the characteristic feature of MDS.
- 6 May 2019
- Published by Taylor & Francis in Leukemia & Lymphoma
- Vol. 60 (11) , 2779-2786
MicroRNA-661 upregulation in myelodysplastic syndromes induces apoptosis through p53 activation and associates with decreased overall survival
MicroRNA (miRNA) dysregulation contributes to myelodysplastic syndromes (MDS), and apoptosis is one of the pathogenic features of MDS. We investigated the dysregulation of miRNA expression and its biological significance in MDS. We compared the expression profiles of miRNAs encoded by chromosome 8 in 65 patients with MDS and 11 controls, and analyzed the in vitro effect of the upregulated miRNA expression. We found that compared to the controls, miR-661 was upregulated by 5.28-fold in patients with MDS. Patients with high miR-661 expression showed significantly decreased overall survival. In vitro study results demonstrated that transfection with a miR-661 mimic induced apoptosis through the activation of p53. These findings suggest that high miR-661 expression can be associated with decreased overall survival and recapitulates apoptosis, the characteristic feature of MDS.
- Open Access
- 1 January 2018 Published in Laboratory Medicine Online
- Vol. 8 (4) , 167-170
Primary Myelofibrosis with MPL S505N Mutation: The First Case Reported in Korea
- 1 January 2018
- Published in Laboratory Medicine Online
- Vol. 8 (4) , 167-170
Open AccessPrimary Myelofibrosis with MPL S505N Mutation: The First Case Reported in Korea
- Open Access
- 1 January 2018
- Published by Laboratory Medicine Online in Laboratory Medicine Online
- Vol. 8 (1) , 7-14
Comparison of the Utility of dnaJ and 16S rDNA Sequences for Identification of Clinical Isolates of Vibrio Species
- 1 January 2018
- Published by Laboratory Medicine Online in Laboratory Medicine Online
- Vol. 8 (1) , 7-14
Open AccessComparison of the Utility of dnaJ and 16S rDNA Sequences for Identification of Clinical Isolates of Vibrio Species
- Open Access
- 1 January 2017
- Published by The Korean Society of Clinical Microbiology in Annals of Clinical Microbiology
- Vol. 20 (4) , 90-96
Assessment of Efflux Activity Using H33342 Accumulation in Tigecycline-ResistantAcinetobacter baumanniiClinical Isolates
Kim CM, et al. Ann Clin Microbiol. 2017 Dec;20(4):90-96. https://doi.org/10.5145/ACM.2017.20.4.90
- 1 January 2017
- Published by The Korean Society of Clinical Microbiology in Annals of Clinical Microbiology
- Vol. 20 (4) , 90-96
Open AccessAssessment of Efflux Activity Using H33342 Accumulation in Tigecycline-ResistantAcinetobacter baumanniiClinical Isolates
Kim CM, et al. Ann Clin Microbiol. 2017 Dec;20(4):90-96. https://doi.org/10.5145/ACM.2017.20.4.90